Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis

Zili Zhang, Wenwei Zhong, David Hinrichs, Xiumei Wu, Andrew Weinberg, Mark Hall, Doran Spencer, Keith Wegmann, James (Jim) Rosenbaum

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Uveitis is a major and common cause of visual disability. Recent studies have shown that Th17 cells are implicated in the pathogenesis of this serious intraocular disorder. Activated T cells express an inducible costimulatory molecule called OX40, and OX40 in turn promotes the activation and proliferation of these lymphocytes. Nevertheless, it is unclear whether OX40 plays a vital role in enhancing the effector function of Th17 cells as well as the severity of uveitis. In this study, we demonstrated an increase of OX40 transcription in ovalbumin-induced uveitis, whereas anti-OX40L antibody substantially inhibited the antigen-specific ocular inflammation. Next, results from flow cytometry showed that activated Th17 cells expressed OX40, and OX40-activating antibody significantly augmented the production of Th17 cytokines in vitro. To validate the impact of OX40 in vivo, we stimulated ovalbumin-specific T cells with the OX40-activating antibody. Compared to donor cells without OX40 activation, adoptive transfer of OX40-stimulated lymphocytes elicited more severe ocular inflammation. Furthermore, an interleukin-17-neutralizing antibody attenuated OX40-mediated uveitis. In conclusion, our findings suggest that activation of OX40 augments Th17 cell function and thereby contributes to ocular inflammation. This study thus enhances our knowledge of costimulatory molecule-mediated immunopathological mechanisms of uveitis and suggests a future therapeutic strategy to treat uveitis by the targeting of OX40.

Original languageEnglish (US)
Pages (from-to)2912-2920
Number of pages9
JournalAmerican Journal of Pathology
Volume177
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Uveitis
Th17 Cells
Cytokines
Antigens
Ovalbumin
Inflammation
T-Lymphocytes
Interleukin-17
Adoptive Transfer
Antibodies
Lymphocyte Activation
Neutralizing Antibodies
Anti-Idiotypic Antibodies
Flow Cytometry
Lymphocytes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. / Zhang, Zili; Zhong, Wenwei; Hinrichs, David; Wu, Xiumei; Weinberg, Andrew; Hall, Mark; Spencer, Doran; Wegmann, Keith; Rosenbaum, James (Jim).

In: American Journal of Pathology, Vol. 177, No. 6, 12.2010, p. 2912-2920.

Research output: Contribution to journalArticle

Zhang, Z, Zhong, W, Hinrichs, D, Wu, X, Weinberg, A, Hall, M, Spencer, D, Wegmann, K & Rosenbaum, JJ 2010, 'Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis', American Journal of Pathology, vol. 177, no. 6, pp. 2912-2920. https://doi.org/10.2353/ajpath.2010.100353
Zhang, Zili ; Zhong, Wenwei ; Hinrichs, David ; Wu, Xiumei ; Weinberg, Andrew ; Hall, Mark ; Spencer, Doran ; Wegmann, Keith ; Rosenbaum, James (Jim). / Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. In: American Journal of Pathology. 2010 ; Vol. 177, No. 6. pp. 2912-2920.
@article{685065ea068a48919b82b90663ad290f,
title = "Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis",
abstract = "Uveitis is a major and common cause of visual disability. Recent studies have shown that Th17 cells are implicated in the pathogenesis of this serious intraocular disorder. Activated T cells express an inducible costimulatory molecule called OX40, and OX40 in turn promotes the activation and proliferation of these lymphocytes. Nevertheless, it is unclear whether OX40 plays a vital role in enhancing the effector function of Th17 cells as well as the severity of uveitis. In this study, we demonstrated an increase of OX40 transcription in ovalbumin-induced uveitis, whereas anti-OX40L antibody substantially inhibited the antigen-specific ocular inflammation. Next, results from flow cytometry showed that activated Th17 cells expressed OX40, and OX40-activating antibody significantly augmented the production of Th17 cytokines in vitro. To validate the impact of OX40 in vivo, we stimulated ovalbumin-specific T cells with the OX40-activating antibody. Compared to donor cells without OX40 activation, adoptive transfer of OX40-stimulated lymphocytes elicited more severe ocular inflammation. Furthermore, an interleukin-17-neutralizing antibody attenuated OX40-mediated uveitis. In conclusion, our findings suggest that activation of OX40 augments Th17 cell function and thereby contributes to ocular inflammation. This study thus enhances our knowledge of costimulatory molecule-mediated immunopathological mechanisms of uveitis and suggests a future therapeutic strategy to treat uveitis by the targeting of OX40.",
author = "Zili Zhang and Wenwei Zhong and David Hinrichs and Xiumei Wu and Andrew Weinberg and Mark Hall and Doran Spencer and Keith Wegmann and Rosenbaum, {James (Jim)}",
year = "2010",
month = "12",
doi = "10.2353/ajpath.2010.100353",
language = "English (US)",
volume = "177",
pages = "2912--2920",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis

AU - Zhang, Zili

AU - Zhong, Wenwei

AU - Hinrichs, David

AU - Wu, Xiumei

AU - Weinberg, Andrew

AU - Hall, Mark

AU - Spencer, Doran

AU - Wegmann, Keith

AU - Rosenbaum, James (Jim)

PY - 2010/12

Y1 - 2010/12

N2 - Uveitis is a major and common cause of visual disability. Recent studies have shown that Th17 cells are implicated in the pathogenesis of this serious intraocular disorder. Activated T cells express an inducible costimulatory molecule called OX40, and OX40 in turn promotes the activation and proliferation of these lymphocytes. Nevertheless, it is unclear whether OX40 plays a vital role in enhancing the effector function of Th17 cells as well as the severity of uveitis. In this study, we demonstrated an increase of OX40 transcription in ovalbumin-induced uveitis, whereas anti-OX40L antibody substantially inhibited the antigen-specific ocular inflammation. Next, results from flow cytometry showed that activated Th17 cells expressed OX40, and OX40-activating antibody significantly augmented the production of Th17 cytokines in vitro. To validate the impact of OX40 in vivo, we stimulated ovalbumin-specific T cells with the OX40-activating antibody. Compared to donor cells without OX40 activation, adoptive transfer of OX40-stimulated lymphocytes elicited more severe ocular inflammation. Furthermore, an interleukin-17-neutralizing antibody attenuated OX40-mediated uveitis. In conclusion, our findings suggest that activation of OX40 augments Th17 cell function and thereby contributes to ocular inflammation. This study thus enhances our knowledge of costimulatory molecule-mediated immunopathological mechanisms of uveitis and suggests a future therapeutic strategy to treat uveitis by the targeting of OX40.

AB - Uveitis is a major and common cause of visual disability. Recent studies have shown that Th17 cells are implicated in the pathogenesis of this serious intraocular disorder. Activated T cells express an inducible costimulatory molecule called OX40, and OX40 in turn promotes the activation and proliferation of these lymphocytes. Nevertheless, it is unclear whether OX40 plays a vital role in enhancing the effector function of Th17 cells as well as the severity of uveitis. In this study, we demonstrated an increase of OX40 transcription in ovalbumin-induced uveitis, whereas anti-OX40L antibody substantially inhibited the antigen-specific ocular inflammation. Next, results from flow cytometry showed that activated Th17 cells expressed OX40, and OX40-activating antibody significantly augmented the production of Th17 cytokines in vitro. To validate the impact of OX40 in vivo, we stimulated ovalbumin-specific T cells with the OX40-activating antibody. Compared to donor cells without OX40 activation, adoptive transfer of OX40-stimulated lymphocytes elicited more severe ocular inflammation. Furthermore, an interleukin-17-neutralizing antibody attenuated OX40-mediated uveitis. In conclusion, our findings suggest that activation of OX40 augments Th17 cell function and thereby contributes to ocular inflammation. This study thus enhances our knowledge of costimulatory molecule-mediated immunopathological mechanisms of uveitis and suggests a future therapeutic strategy to treat uveitis by the targeting of OX40.

UR - http://www.scopus.com/inward/record.url?scp=78650202203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650202203&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2010.100353

DO - 10.2353/ajpath.2010.100353

M3 - Article

C2 - 20952591

AN - SCOPUS:78650202203

VL - 177

SP - 2912

EP - 2920

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -